Impact BioMedical Inc. announced the issuance of U.S. Patent No. 11,985,973, titled 'Insect Repelling Composition,' under its 3F™ technology platform. This patent, set to expire in February 2039, expands the company's existing 3F™ patent estate. It covers compositions and formulations derived from plants and plant-produced fragrances.
These formulations are designed to act as natural insect repellents, with the potential to reduce insect landings and bites in outdoor environments. The technology works by inhibiting insects' olfactory receptors, effectively 'blinding' them to human presence. Potential applications include human insect repellents and additives for detergents, shampoos, or lotions.
The World Health Organization reports that vector-borne diseases account for approximately 17% of all infectious diseases globally, highlighting a significant market need for effective solutions. IBO CEO Frank D. Heuszel stated the company is accelerating discussions with potential partners to bring 3F™ products to market in the US and worldwide.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.